Advances in Magnetic Nanoparticle-Driven Delivery of Gene Therapies towards Prostate Cancer
Open Access
- 15 September 2021
- journal article
- review article
- Published by Hindawi Limited in Journal of Nanomaterials
- Vol. 2021, 1-10
- https://doi.org/10.1155/2021/6050795
Abstract
Advances in Magnetic Nanoparticle-Driven Delivery of Gene Therapies towards Prostate Cancer: Conventional treatment possibilities for one of the most common diseases among men, i.e., prostate cancer has several side effects. Gene-based therapy such as siRNA, CRISPR/Cas9, pDNA, and miRNA have emerged as an alternative, combating posttherapy side effects and drug resistance. Magnetic nanoparticles have been appropriately modified and functionalized to efficiently deliver the gene therapy-based active compounds to prostate tumor cells. The main purpose of this review article is to highlight the strategies currently being utilized for the treatment of prostate cancer using magnetic nanoparticles for delivery of genetic material using both the passive and active (ligand-based) targeting. It further discusses the challenges in efficient delivery of therapeutics to tumor sites and their remedial approaches. Finally, it provides a glimpse of future advances for tumor-specific modifications of magnetic nanoparticles to combat prostate cancer.Keywords
Funding Information
- China Postdoctoral Science Foundation (2018M630866, 21774039, 21574050, 51803067)
This publication has 99 references indexed in Scilit:
- Efficient genome editing in zebrafish using a CRISPR-Cas systemNature Biotechnology, 2013
- Tumor-Associated Antigens for Specific Immunotherapy of Prostate CancerCancers, 2012
- Promising plasmid DNA vector based on APTES-modified silica nanoparticlesInternational Journal of Nanomedicine, 2012
- Progress in Gene Therapy for Prostate CancerFrontiers in Oncology, 2012
- Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomesInternational Journal of Nanomedicine, 2011
- siRNA delivery systems for cancer treatmentAdvanced Drug Delivery Reviews, 2009
- Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and TherapyChemMedChem, 2008
- Interfering with disease: a progress report on siRNA-based therapeuticsNature Reviews Drug Discovery, 2007
- Magnetic poly ε-caprolactone nanoparticles containing Fe3O4and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse modelJournal of Drug Targeting, 2007
- Escort aptamers: a delivery service for diagnosis and therapyJCI Insight, 2000